# R(+)XK469 in Treating Patients With Advanced Neuroblastoma

> **NCT00028522** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 85 (actual)

## Conditions studied

- Disseminated Neuroblastoma
- Localized Unresectable Neuroblastoma
- Recurrent Neuroblastoma
- Regional Neuroblastoma

## Interventions

- **DRUG:** R(+)XK469

## Key facts

- **NCT ID:** NCT00028522
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** 2009-09
- **Final completion:** —
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2013-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00028522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00028522, "R(+)XK469 in Treating Patients With Advanced Neuroblastoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00028522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*